The Usher 1B protein, MYO7A, is required for normal localization and function of the visual retinoid cycle enzyme, RPE65. by Lopes, Vanda S et al.
UCLA
UCLA Previously Published Works
Title
The Usher 1B protein, MYO7A, is required for normal localization and function of the visual 
retinoid cycle enzyme, RPE65.
Permalink
https://escholarship.org/uc/item/4051q9hf
Journal
Human molecular genetics, 20(13)
ISSN
0964-6906
Authors
Lopes, Vanda S
Gibbs, Daniel
Libby, Richard T
et al.
Publication Date
2011-07-01
DOI
10.1093/hmg/ddr155
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
The Usher 1B protein, MYO7A, is required for
normal localization and function of the visual
retinoid cycle enzyme, RPE65
Vanda S. Lopes1,2,3,4, Daniel Gibbs3,{, Richard T. Libby5,{, Tomas S. Aleman6, Darcy L. Welch1,
Concepcio´n Lillo3,§, Samuel G. Jacobson6, Roxana A. Radu1, Karen P. Steel5,7
and David S. Williams1,2,3,∗
1Jules Stein Eye Institute and 2Department of Neurobiology, UCLA School of Medicine, 200 Stein Plaza, Los Angeles,
CA 90095, USA, 3Department of Pharmacology and Department of Neurosciences, UCSD School of Medicine,
La Jolla, CA 92093, USA, 4Centre of Ophthalmology, IBILI, University of Coimbra, 3048 Coimbra, Portugal, 5MRC
Institute of Hearing Research, University Park, Nottingham NG7 2RD, UK, 6Scheie Eye Institute, Department of
Ophthalmology, University of Pennsylvania, Philadelphia, PA 19104, USA and 7The Wellcome Trust Sanger Institute,
Hinxton, Cambridge, CB10 1SA, UK
Received February 7, 2011; Revised and Accepted April 7, 2011
Mutations in theMYO7A gene cause a deaf-blindness disorder, known as Usher syndrome 1B. In the retina, the
majority of MYO7A is in the retinal pigmented epithelium (RPE), where many of the reactions of the visual reti-
noid cycle take place. We have observed that the retinas of Myo7a-mutant mice are resistant to acute light
damage. In exploring the basis of this resistance, we found that Myo7a-mutant mice have lower levels of
RPE65, the RPE isomerase that has a key role in the retinoid cycle. We show for the first time that RPE65 nor-
mally undergoes a light-dependent translocation to become more concentrated in the central region of the RPE
cells. This translocation requires MYO7A, so that, in Myo7a-mutant mice, RPE65 is partly mislocalized in the
light. RPE65 is degraded more quickly in Myo7a-mutant mice, perhaps due to its mislocalization, providing a
plausible explanation for its lower levels. Following a 50–60% photobleach, Myo7a-mutant retinas exhibited
increased all-trans-retinyl ester levels during the initial stages of dark recovery, consistent with a deficiency in
RPE65 activity. Lastly, MYO7A and RPE65 were co-immunoprecipitated from RPE cell lysate by antibodies
against either of the proteins, and the two proteins were partly colocalized, suggesting a direct or indirect
interaction. Together, the results support a role for MYO7A in the translocation of RPE65, illustrating the
involvement of a molecular motor in the spatiotemporal organization of the retinoid cycle in vision.
INTRODUCTION
Usher syndrome is a recessively inherited disorder of combined
deafness and blindness. In Usher syndrome type 1, defects in
the cochlear hair cells result in congenital, profound deafness
and abnormalities in the retina lead to progressive degeneration
of the photoreceptor cells after development. Mutations in the
MYO7A gene cause Usher syndrome type 1B (1). Shaker1 mice
have loss-of-function mutations in the orthologous gene,
Myo7a, and thus serve as a model of Usher 1B (2).
MYO7A is an unconventional myosin motor protein (3,4),
expressed both in retinal photoreceptors and the retinal pig-
mented epithelium (RPE) (5,6). Studies of shaker1 mice
have demonstrated that MYO7A has important functions in
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both cell types. In the photoreceptors, MYO7A is required for
the normal transport of opsin through the ciliary plasma mem-
brane to the outer segment (7), and, in the RPE, it functions in
the movement of melanosomes and phagosomes (8–10).
However, as with most of the mouse models of the other
Usher 1 genes, shaker1 mice have been found not to
undergo retinal degeneration, at least under standard vivarium
conditions (11).
We began the present study by attempting to see if shaker1
retinas could be induced to degenerate, if stressed. We tested
whether shaker1 mice were more susceptible to retinal
degeneration that occurs in response to high-light exposure
(12), as already shown for several other animal models of
retinal degeneration (13–17). To our surprise, we found
that retinas of shaker1 mice were more resistant to light
damage than retinas of wild-type (WT) mice on the same
genetic background.
Following the absorption of a photon of light, rhodopsin
becomes bleached. It is then regenerated following a series
of reactions, known as the visual retinoid cycle, that involves
the formation of 11-cis retinal, the light-sensitive ligand that
binds to opsin (18–21). Defects in rhodopsin regeneration
can afford protection against light damage (22). Hence, our
finding on resistance to light damage in shaker1 mice led us
to study the requirement for MYO7A in the retinoid cycle.
Our study focused on RPE65, an enzyme that catalyzes the
conversion of all-trans-retinyl esters to 11-cis retinol, a key
isomerization step in the retinoid cycle (23–25). We found
that RPE65 translocates within the RPE in response to
light. We report evidence that MYO7A functions in this trans-
location, and is thus an important element in the spatiotem-
poral regulation of the visual retinoid cycle.
RESULTS
Retinal degeneration in response to short-term high-light
exposure
Shaker1 mice carrying the Myo7a4626SB allele on a mixed
genetic background (see Materials and Methods) were used
in an acute light damage experiment. They were determined
by polymerase chain reaction (PCR) to be homozygous for
the normal Leu450 allele of RPE65. Light microscopy of
retinas from animals kept for 10 days after a 2 h exposure to
15 000 lux showed a significant loss of photoreceptor cells in
WT mice (Fig. 1A and C). From a quantitative analysis of
photoreceptor cells along the entire dorso-ventral axis, it is
clear that the central photoreceptors were especially affected
(Fig. 1E). In contrast, high-light-exposed shaker1 retinas
were comparable with unexposed retinas (Fig. 1B, D, E).
Electroretinogram (ERG) measurements were consistent with
the light microscopy. Amplitudes of the a-wave (the photo-
receptor component of the ERG) were reduced by 50% in
exposed WT retinas, whereas those of shaker1 (MYO7A
null) retinas were unaffected by the high-light exposure.
This experiment was repeated with shaker1mice on a
C57BL6 genetic background. The Met450 variant of the
RPE65 protein is expressed in the C57BL6 genetic background,
and is present at significantly lower levels than Leu450 RPE65
(26,27). In this case, neither the control nor mutant mice
showed any damage to a 2 hr exposure to light of 15 000 lux.
Cellular amounts of visual cycle proteins
Because of the resistance of shaker1 retinas to light damage,
and that defects in rhodopsin regeneration have been shown
to afford protection against light damage (22), we tested
whether the loss of MYO7A affects the cellular amounts
of proteins involved in the visual cycle. Western blot analysis
showed that the level of RPE65 was reduced in shaker1 retinas
(Fig. 2A and B). However, the levels of other RPE proteins,
such as lecithin:retinol acyl transferase (LRAT), cellular
retinaldehyde-binding protein (CRALBP) and an RPE intra-
cellular retinal GPCR (RGR), were not appreciably different.
RPE65 levels in retinas obtained from mice during the
afternoon (i.e. light-adapted (LA) for .6 h on their regular
light cycle) were reduced by 30–50% in the absence of
MYO7A. Interestingly, the level of RPE65 in heterozygote
(+/sh1) retinas was in between the levels of WT and
shaker1 retinas (Supplementary Material, Fig. S1).
Figure 1. Shaker1 retinas are resistant to light damage. Light micrograph sections of retinas in the region located 0.5 mm dorsal to the optic nerve (ON)
demonstrate the thickness of the photoreceptor cell nuclear layer in WT (A and C) and shaker1 (B and D) mice exposed to regular (A and B) or damaging
(C and D) light. All animals were reared under the normal light/dark cycle. All images are of the same magnification; scale bar ¼ 50 mm. OS, outer
segment layer; IS, inner segment layer; NL, photoreceptor nuclear layer. (E) Quantification of photoreceptor cell nuclei at 0.5 mm intervals from the optic
nerve head in dorso-ventral sections of retinas of the animals described in (A)–(D). Each value corresponds to the mean obtained from retinas of three different
animals (SEM ,0.55 in all cases).
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The relative reduction in RPE65 was irrespective of genetic
background, and of whether or not that background carries
the normal Leu450 allele of RPE65 or the Met450 variant.
In shaker1 mice on the C57BL6 background, the Met450
variant is reduced further below than that in WT C57BL6
mice (Fig. 2A and B).
In further analysis, we found that the reduction in RPE65
due to loss of MYO7A was slightly more pronounced in LA
retinas than in dark-adapted (DA) retinas. This difference
was due to a small increase in RPE65 levels that occurs in
WT retinas in response to light, but not in shaker1 retinas.
Retinas from mice that were DA for 16 h overnight, and
then either kept in the dark or exposed to room lights for
2 h were compared. The 2 h exposure to light effected a
25% increase over DA RPE65 levels in WT retinas, but not
in shaker1 retinas (Fig. 2C and D).
Degradation of RPE65
We tested whether the reduced levels of RPE65 in the shaker1
retina might be linked to increased protein degradation. The
rate of loss of RPE65 was determined by treating eyecups with
cycloheximide (CHX) to inhibit additional protein synthesis,
and then measuring the amount of RPE65 at intervals. The
amount of RPE was found to decrease more quickly in
shaker1 eyecups; after 8 h, it had dropped by 50%, whereas in
heterozygous eyecups it has decreased by only 25% over the
same period (Fig. 2E and F). A similar experiment was per-
formed with 293T cells that stably expressed RPE65, LRAT
and CRALBP (23). In these cells, transfection with
GFP-MYO7A increased the half-life of RPE65 from 4 to
5.5 h. Together, these results indicate that increased degradation
contributes to the lower amount of RPE65 in shaker1 retinas.
Figure 2. Levels of visual cycle proteins. (A) Ten micograms of WT and Sh1 eyecups, expressing the Leu450 or Met450 RPE65 variant, were probed by western
blot for several visual cycle proteins. Actin was used as loading control. (B) Bar graph showing the relative percent of RPE65, measured from western blots, such
as that shown in (A), by densitometry. Error bars represent +SEM, where n ≥ 3. Sh1 have reduced levels of RPE65 (30% less; P ¼ 0.002), independent of the
RPE65 variant expressed in the RPE. (C) Western blotting analysis of dark-adapted (DA) (16 h) and LA (16 h dark + 2 h light) eyecups of WT and Sh1 mice.
Actin was used as loading control. (D) Bar graph indicating the relative amount of RPE65 determined by densitometry (n ¼ 4, error bars indicate SEM; prob-
ability of no significant difference between WT light and dark ¼ 0.005). (E) Western blot of RPE65 in shaker1 (sh1/sh1) and heterozygous eyecups incubated
for different lengths of time with CHX to inhibit protein synthesis. (F) Graph of relative amount of RPE65 with respect to length of time with CHX, showing
accumulated data determined by densitometry of western blots from different experiments; error bars indicate SEM.
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Subcellular localization of RPE65
RPE65 is an RPE-specific protein. We studied its distribution
within the RPE by immunofluorescence and immunoelectron
microscopy. First, we observed that the distribution of
RPE65 differs between LA and DA retinas of WT mice. In
the dark, RPE65 is distributed more extensively throughout
the cell; its distribution extends to the tips of the outer seg-
ments. But upon exposure to light (100 lux, 2 h), it
becomes concentrated more in the central region, so that a
space is evident between the immunofluorescence labeling
of the outer segments and that of RPE65 (Fig. 3A, upper
panels). This difference occurs in mice containing either of
the two RPE65 alleles (Leu450 or Met450) tested. It can
also be observed by immunoelectron microscopy (Supplemen-
tary Material, Fig. S3).
Secondly, we observed that the distribution of RPE65 in
shaker1 RPE differs from that in the WT. In particular, the
protein does not undergo the same redistribution upon
exposure to light. RPE65 extends to the level of the tips of
the outer segments in both LA and DA shaker1 retinas. This
distribution is comparable with that in DA WT retinas
(Fig. 3A–C). The same observation was made with mice pos-
sessing a different mutation of Myo7a. Polka mice are not null
for MYO7A, but express a mutant form of the protein that is
truncated at its C-terminus. Like shaker1 mice, these mice
have defects in cochlear hair cell development, and the mela-
nosomes in their RPE are mislocalized (28). Supplementary
Material, Figure S2 shows the distribution of RPE65 in LA
WT and polka mutant RPE. In the WT RPE, RPE65 appears
more concentrated in the central region of the RPE than in
the mutant RPE, where more RPE65 labeling is evident in
the apical RPE, below the cell nuclei.
Quantitative immunoelectron microscopy showed that the
relative amount of RPE65 was increased somewhat in the
central third of the RPE, following light exposure of WT
retinas. No such increase in RPE65 was observed in the
shaker1 RPE (Fig. 3D; Supplementary Material, Fig. S3).
While the division of the RPE into three equal regions did
not correspond to any given subcellular structures, and there-
fore may underestimate the effect, these observations were
nevertheless consistent with the immunofluorescence data.
Together, our results on the subcellular localization of
RPE65 show that there is a light-dependent change in the dis-
tribution of the protein, and that this phenomenon is abolished
in the absence of MYO7A function.
Recovery after photobleach
Because the shaker1 RPE showed compromised RPE65 levels
and distribution, we tested whether these effects were sufficient
to manifest defects in retinoid levels and the retinal photore-
sponse after a photobleach. Experiments were performed
with shaker1 mice and littermate controls on a 129 Sv back-
ground (homozygous for Leu450 RPE65), that were exposed
to a 50% photobleach, and then placed in the dark.
After 5 min in the dark, retinoid levels were similar between
WT and shaker1 RPE, except the level of all-trans-retinyl
palmitate, the RPE65 isomerase substrate. All-trans-retinyl
ester levels were 54% higher in shaker1 RPE than in WT
RPE (P, 0.03), suggesting less RPE65 activity (Fig. 4). In
heterozygous (+/sh1) RPE, the mean level of all-trans-retinyl
palmitate was 22% more than that in WT RPE, although stat-
istical analysis of the data indicated no significant difference
(P . 0.07).
Figure 3. Subcellular localization of RPE65 is dependent on light and MYO7A. (A) Paraffin sections (5 mm) of WT and shaker1 (Sh1) retinas, either DA or LA,
labeled with rhodopsin (red) and RPE65 (green) antibodies. RPE65 and opsin labeling are juxtaposed, except in the LA WT retina, where RPE65 is depleted
from the apical RPE, and its labeling does not extend to the tips of the opsin-labeled outer segments. Ch, choroid; RPE, retinal pigment epithelium; ROS, rod
outer segments. Scale bar ¼ 15 mm. (B) Higher magnification of sections labeled in the same manner as those in A, comparing LA WT and shaker1 retinas.
Scale bar ¼ 2.5 mm. (C) Bar graph of measurements of the width of the immunofluorescence (IF) labeling in WT and shaker1 RPE sections, prepared and
labeled as in (A) and (B). (D) Bar graph illustrating the distribution of RPE65 in the apical, central and basal regions of the RPE, in relation to the genotype
and lighting conditions. The data were obtained from gold particle counts following immunogold labeling and electron microscopy. Basal to apical sections of
the RPE were divided into equal thirds, and the gold particles were counted in each region.
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The ERG was used to monitor photoreceptor activation
(a-wave), and recovery of activation after light exposure.
The waveforms of DA ERGs from shaker1 and +/sh1 mice
were indistinguishable (Supplementary Material, Fig. S4,
inset). A light exposure was then used to examine the kinetics
of recovery of photoreceptor function after a photobleach
(50%). The measured mean function describing the time
course of recovery of the a-wave amplitude (expressed as a
fraction of the DA amplitude) was slightly slower in shaker1
compared with +/sh1 mice, but statistical analysis indicated
no significant difference between the two functions (Sup-
plementary Material, Fig. S4). At 50 min after the bleach,
a-wave amplitude had reached levels of recovery in shaker1
(38+ 21% of the DA amplitude) and +/sh1 (51+ 17%)
mice that were not significantly different (P ¼ 0.38). Compar-
able results were obtained using the ERG b-wave to examine
recovery. At 50 min after the bleach, recovery of the b-wave
amplitude was 34+ 11% in shaker1 and 41+ 14% in +/sh1
mice (P ¼ 0.15).
Co-immunoprecipitation of MYO7A and RPE65
To test for a possible direct or indirect link between MYO7A
and RPE65, we performed co-immunoprecipitation exper-
iments on WT RPE. Small, but reproducible amounts of
MYO7A and RPE65 were co-immunoprecipitated from RPE
cell lysate with antibodies against the other protein, suggesting
an interaction between the two proteins (Fig. 5). Neither
protein was precipitated when a GST antibody (non-specific
control) or beads alone were used, indicating the specificity
of the MYO7A–RPE65 interaction. In addition, several
other proteins, such as CRALBP and the microtubule-
associated protein, LC3, did not associate with either precipi-
tate. This result suggests that the RPE contains a complex that
includes both MYO7A and RPE65, and which may be related
to the MYO7A-dependent translocation of RPE65.
Colocalization of MYO7A and RPE65
MYO7A has been shown by immunolabeling of retinal sec-
tions to be distributed throughout the RPE, especially in the
apical part of the cell body and in the apical processes
(5,6,10,29,30). The distribution of RPE65 (cf. Fig. 3) overlaps
with part of this described distribution for MYO7A. Here, we
tested for colocalization of the two proteins by two different
approaches. First, cells from the human RPE cell line,
ARPE19, were co-transfected with GFP-MYO7A and
RFP-RPE65, and confocal images were sequentially collected
for each fluorophore from the same optical plane. Although
the distributions of the two proteins differed, some overlap
was evident, indicating partial colocalization (Fig. 6A–C).
Secondly, we immunolabeled whole mounts of LA eyecups
from 129 Sv mice, prepared as described previously (31),
with antibodies against MYO7A and RPE65. Colocalization
of the two proteins was evident primarily in the central
regions of the RPE (Fig. 6D–G).
DISCUSSION
Based on the observation that shaker1 retinas are less suscep-
tible to acute light damage, we investigated whether MYO7A
was linked to the visual cycle. We show that retinas lacking
MYO7A contain less of the visual cycle enzyme, RPE65,
due to increased degradation. Moreover, the enzyme that is
present fails to undergo light-dependent translocation, and
the total isomerase activity is impaired. MYO7A and
Figure 5. Immunoprecipitation of MYO7A with RPE65 antibody, and RPE65
with MYO7A antibody. Lane 1 shows immunolabeling of a western blot of
the retinal lysate with MYO7A, RPE65, CRALBP and LC3
(microtubule-associated protein 1A/1B-light chain 3) antibodies. Lanes 2–5
show labeling of proteins associated with the protein A beads, following
western blotting and using the same antibodies. GST antibody was used as
a test for non-specific interactions (lane 3), and lack of antibody was used
as a control for non-specific association with protein A beads (lane 2).
Small amounts of MYO7A (lane 4) and RPE65 (lane 5) seem to associate
directly or indirectly with the other protein, whereas two control proteins,
CRALBP and LC3, do not.
Figure 4. Measurements of retinoid levels during dark recovery following a
photobleach. Levels of all-trans-retinyl palmitate (RP), 11-cis-retinol
(ROL), all-trans-retinol and 11-cis-retinaldehyde (RAL) in eyecups of
shaker1, +/sh1 and WTmice, after 5 min in the dark following a 50–60%
photobleach. All mice were homozygous for RPE65 Leu450. ∗P , 0.01.
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RPE65 appear to be associated with each other, suggesting
that MYO7A functions in the localization of the visual cycle
enzyme.
Resistance to light damage, similar to that observed in
shaker1 mice in the present study, was initially reported in
strains of albino mice (32) that were found later to carry a
sequence variation in Rpe65 (26,27). It has also been
documented in Rpe65 knockout mice (22). Protection has
been attributed to slowness in rhodopsin regeneration due to
reduced RPE65 isomerase activity (27,33,34). The observed
resistance to acute light damage in retinas of shaker1 mice,
homozygous for the Leu450 allele of RPE65, is therefore con-
sistent with a role for MYO7A in the visual cycle. Such a role
is also indicated by reduced RPE65 levels, lack of RPE65
Figure 6. Fluorescence localization of MYO7A and RPE65. (A–C) Fluorescence images of an ARPE19 cell transfected with GFP-tagged human MYO7A
(GFP-hMYO7A) (A) and RFP-tagged human RPE65 (RFP-hRPE65) (B). A merge of the green and red channels is shown in (C). Partial overlap in the dis-
tribution of the two proteins is evident. (D–H) Immunofluorescence labeling of MYO7A and RPE65 in a whole mount of a mouse eyecup. Confocal optical
sections show different regions of the RPE, from basal (D) to apical (G). A reconstruction of the apical-basal axis, with relative locations of the optical sections
(D–G), is shown (H). Arrowheads in (D)–(G) indicate the region corresponding to the apical–basal reconstruction. Scale bars ¼ 5 mm.
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light-dependent translocation and increased retinyl ester
accumulation in the shaker1 RPE, together with the associ-
ation of MYO7A and RPE65 by co-immunoprecipitation and
colocalization, all of which indicate that MYO7A function
supports RPE65 isomerase activity.
Higher retinyl ester levels were measured in MYO7A-null
eyecups during 5 min of dark recovery following a photo-
bleach. Retinyl esters accumulate in two separate pools, in
lipid droplets and in endoplasmic reticulum membranes (35).
Here, we measured overall levels, making no distinction
between these two pools; it is possible that the retinyl ester
increase may have been due to only one of the pools, most
likely the latter, which has been regarded as the ‘isomerase
pool’ (35). We did not detect a difference in the levels of
11-cis retinaldehyde. However, this would have been unli-
kely, given that eyecups were used and most of this retinoid
would have come from that remaining in the photoreceptor
outer segments after the 50–60% photobleach. The amount
of opsin in shaker1 retinas is similar to that in WT retinas
(7). Previous studies, using similar experiments involving
partial photobleaches, have also shown that retinyl ester
levels are a more sensitive measure of RPE65 isomerase
activity than 11-cis-retinal levels (36). The lack of significant
difference in the ERG response during the dark recovery is
consistent with the finding of no difference in 11-cis retinal
levels, although, in this case, the comparison was made over
a longer dark recovery period (50 min), and only between
shaker1 mice and heterozygous (+/sh1) littermates (since
WT congenic controls were unavailable for these exper-
iments); +/sh1 retinas appear to possess levels of RPE65
(Supplementary Material, Fig. S1) and retinyl esters (Fig. 5)
that are between those found for shaker1 and WT. In con-
clusion, the .50% increase in all-trans-retinyl palmitate in
shaker1 eyecups compared with WT eyecups, during short-
term dark recovery after a photobleach, is a strong indication
of impaired RPE65 activity in the absence of MYO7A.
RPE65 has been reported previously to be present in both
the cytosolic and membrane fractions of RPE cells (37). It
was suggested that palmitoylation of RPE65 provides a
switch that allows for membrane association in a light-
dependent manner (38); however, the association of RPE65
with membranes has since been shown to be independent of
palmitoylation (39). Here, we provide evidence that a light
exposure that follows dark adaptation results in an altered dis-
tribution of RPE65 within the RPE cell, with an increased con-
centration in the central region, where extensive smooth
endoplasmic reticulum (SER) is present. RPE65 associates
with retinol dehydrogenase 5 and retinal G protein-couple
receptor (RGR) in a multi-protein complex on the SER
(40,41). Significantly, the correct association of RPE65 with
phospholipid membranes has recently been reported to be
critical for its retinoid isomerization activity (41). This obser-
vation, coupled with the current finding of increased all-trans
retinal ester levels in shaker1 RPE during dark recovery,
suggests that MYO7A-dependent translocation of RPE65 to
SER membrane in the central RPE helps regulate RPE65
activity in response to light. The lower level and shorter half-
life of RPE65 in the absence of MYO7A suggests that mislo-
calization resulting from lack of translocation exposes RPE65
to faster proteolysis.
The dependence of this translocation of RPE65 upon
MYO7A, and the association of MYO7A and RPE65 by
partial co-immunoprecipitation and colocalization, is consist-
ent with the participation of MYO7A in transporting RPE65,
either directly or indirectly. An indirect means might involve
MYO7A transport of SER membrane vesicles with which
RPE65 is associated. Interestingly, class-5 unconventional
myosins have been shown to associate with and move parts
(vesicles or extensions) of ER in a variety of systems, such
as squid axon (42), budding yeast (43) and dendrites of Pur-
kinje cells (44–47). Moreover, MYO7A has already been
shown to function like a MYO5 in the RPE with respect to
another role: the mechanism by which it transports RPE mel-
anosomes is comparable to how MYO5A transports melano-
somes in melanocytes (10,48).
Usher syndrome involves progressive retinal degeneration.
Mutant phenotypes in the retinas of Myo7a-mutant mice
suggest possible underlying causes of degeneration in Usher
1B patients. A number of different such phenotypes have
been described previously (7–10,49). Of these, the ones
most likely to compromise photoreceptor and RPE cell
health are an abnormally high level of opsin in the connecting
cilium, slowed distal migration of the disk membranes and a
delayed digestion of phagocytosed photoreceptor disk mem-
branes (7,9). These phenotypes indicate deficiencies in the
overall turnover of the outer segment disk membranes. It has
been known for some time that complete disruption of any
one of the stages of this turnover, such as disk morphogenesis
in rds mice (50) or phagocytosis of the disk membrane by the
RPE (51), causes retinal degeneration. In the present report,
we describe an additional mutant phenotype that could con-
tribute to retinal degeneration in Usher 1B. Loss-of-function
mutations in the RPE65 gene result in Leber congenital
amaurosis, a recessively inherited blindness (52–54).
Although impaired RPE65 function resulting from lack of
MYO7A appears unlikely to be sufficient in itself to cause
retinal degeneration in Usher 1B, it may contribute by
adding further injury. Usher 1B may be the result of a com-
bination of compromised, but not complete loss of function
in several critical RPE-photoreceptor cell processes. In
Usher 1B, one or more of these mutant phenotypes may be
more severe than in mouse retinas, given that none of the
mutant Myo7a mouse lines manifest retinal degeneration,
including those with null alleles (55).
In conclusion, together our results indicate a role for
MYO7A in the spatiotemporal regulation of the visual retinoid
cycle. They suggest that MYO7A functions by mediating
light-dependent translocation of RPE65. In addition, we
propose that Usher 1B is likely to include defects in the
visual cycle.
MATERIALS AND METHODS
Mice
All procedures conformed to institutional animal care and use
authorizations, and with regulations established by the
National Institutes of Health and the UK Home Office.
Shaker1 mice, carrying the 4626SB allele, which is a
Gln720X mutation in Myo7a (56), effecting a null mutation
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(7), were used. This allele is referred to as simply shaker1
(sh1) in this report. Mice were genotyped as described pre-
viously (57). For the light damage study, mice were from
an inbred colony on a mixed genetic background of 50%
CBA/Ca, 50% BS, with some BALBc. They carried the
WT allele at the albino locus, and the WT RPE65
(Leu450). For the other studies, mice were on either the
C57BL/6HNsd (Harlan C57BL/6) genetic background, which
contains the RPE65 Met450 variant, or backcrossed three gen-
erations from the C57BL6 stock on to the 129S2/SvPasCrl
background (Charles River Laboratories) and selected for the
WT RPE65 (Leu450).
Polka mice, from Dr Ulrich Mueller’s lab, were reared
under similar conditions. These mice carry a mutation
(c.5742 + 5G.A) that affects splicing of the Myo7a tran-
script, resulting in MYO7A that lacks the C-terminal FERM
domain (28). These mice had been crossed with 129S1/
SvImJ mice, and were homozygous for the WT RPE65
(Leu450).
Mice were kept on a 12 h light/12 h dark cycle under
10–50 lux of fluorescent lighting during the light cycle. DA
mice were handled using infrared converting binoculars.
Except for the light damage experiment and photobleaching
in the retinoid and ERG experiments (see below), light adap-
tation involved exposure to room fluorescent lighting of
100 lux. For comparisons of dark and light adaptation,
mice were DA for 16 h from late afternoon; LA mice were
then exposed to 2 h of room lighting.
Light damage experiment
The pupils of each mouse were dilated 2 min before the onset of
the light exposure, using topical atropine sulfate (600 mg/ml sol-
ution). The mice were placed in an animal cage lined with alumi-
num foil. The bottom of the cage had a dish of water, pellets of
food and cut up pieces of fruit. The mice were exposed to 15
000 lux for 2 h. They were monitored throughout this period,
and kept alert with their heads exposed. This was critical since
the shaker1 mice are much more active than their controls; it
was important to keep the controls as active. The cage tempera-
ture was continuously monitored with a digital thermometer and
maintained within 38C of room temperature. After exposure, the
animals were returned to their vivarium, and maintained on the
normal 12 h light/12 h dark cycle. Ten days after the high-light
exposure, ERG measurements were obtained from the left eye of
each animal, and both eyes were then enucleated and processed
for light and electron microscopy.
Genotyping method for determining variant of RPE65
Rpe65 was analyzed by the PCR restriction fragment length
polymorphism method. DNA was derived from mouse tails
by standard procedures, and PCR amplified with the forward
primer, 5′-GCATACGGACTTGGGTTGAATCAC-3′, and
the reverse primer, 5′-GGTTGAGAAACAAAGATGGGT
TCAG-3′. The resulting PCR product is 231 nt in length.
The L450 variant contains an MwoI site at nt 142–151 that
is absent in the M450 variant. Digestion with MwoI therefore
resulted in two bands of 142 and 89 bp for L450, and one
band of 231 bp for M450.
Light and electron microscopy
Eyes were enucleated and posterior eyecups were fixed by
immersion. The eyecups were fixed in 2% glutaraldehyde +
2% formaldehyde in 0.1 M cacodylate buffer, followed by sec-
ondary fixation in 1% OsO4 and processing for embedment in
Epon.
Photoreceptor cell density was determined from images of
dorso-ventral semithin (0.7 mm) sections stained with tolui-
dine blue. Regions that were spaced at 0.5 mm intervals
from the optic nerve head were identified; the central retina
corresponds approximately with the region that is 0.5 mm
dorsal to the optic nerve head. In each region, at least three
representative columns of photoreceptor cell nuclei were
counted to determine the thickness of the nuclear layer in
terms of the number of rows of nuclei.
Alternatively, eyecups were fixed in 0.25%
glutaraldehyde + 4 formaldehyde in 0.1 M cacodylate buffer,
pH 7.4 and processed for embedment in LR White. Ultrathin
sections (70 nm) were subjected to saturated sodium periodate,
blocked with 4% bovine serum albumin (BSA) in antibody
buffer (TBS + 1% Tween-20) for 1 h at room temperature
and incubated with RPE65 antibody in buffer overnight at
48C. Sections were then washed and incubated with goat anti-
rabbit IgG conjugated to 12 nm gold (Jackson Lab), and
stained with uranyl acetate and lead citrate. Sections from
RPE65 knockout mice were used as negative control. Immu-
nolabeling density was determined by counting gold particles
along the RPE. Random images were taken along the RPE
layer, cells were divided into three equal regions (apical,
central and basal) and gold particles were counted within
each region. Statistical analyses for these and other exper-
iments were performed using one-tail, Student t-tests.
Immunofluorescence analysis
For immunofluorescence microscopy, eyes were fixed in 4%
formaldehyde in phosphate-buffered saline (PBS), and
embedded in optimal cutting temperature compound (for cryo-
sectioning) or paraffin. Sections (5 mm for paraffin, 8 mm for
frozen) were rehydrated and blocked in 4% BSA in PBS. Auto-
fluorescence was quenched with 50 mM ammonium chloride in
PBS. After incubation with antibodies, sections were mounted
using anti-fading mounting media containing 4′,6-diamidino-2-
phenylindole (Fluorogel II, EMS, USA) and analyzed by confo-
cal or epifluorescence microscopy. The primary antibodies
were rabbit polyclonal (Pin5 from Dr Wenzel) or mouse mono-
clonal (from Dr Thompson) anti-RPE65 and mouse monoclonal
anti-opsin (1D4 from Dr Molday). The secondary antibodies
were Alexa 568 or Alexa 488 goat anti-rabbit or goat anti-
mouse IgG (Molecular Probes, OR, USA).
Western blot analysis
Mouse eyecups were homogenized in 50 mM Tris, pH 7.4,
100 mM NaCl, 1 mM ethylenediaminetetraacetic acid
(EDTA), 1 mM MgCl2, 1 mM dithiothreitol (DTT), and com-
plete protease inhibitor cocktail from Sigma. Equivalent
protein concentrations were fractionated on a 4–12% Bis–
Tris gel (Invitrogen) and transferred to polyvinylidene fluoride
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(PVDF) membrane (Millipore). Membranes were blocked and
then probed with the rabbit anti-RPE65 (1:1000), mouse anti-
actin (JLA20) (1:1000), rabbit anti-RGR (from Dr Wenzel)
(1:1000), rabbit anti-LRAT (from Dr Palczweski) (1:5000),
rabbit anti-LC3 (microtubule-associated protein 1A/1B-light
chain 3) (from Abgent) or rabbit anti-CRABLP (from Dr
Saari) (1:1000), or washed, and incubated with horseradish
peroxidase-conjugated anti-rabbit antibody (1:30 000, Sigma).
Bound antibody was detected using the ECL Dura Western
Blotting detection system (Thermo Scientific). The chemilumi-
nescence signal detected was used to perform densitometry
analysis in ImageJ, where the intensity was correlated with rela-
tive protein levels. Samples were analyzed in triplicate.
Half-life of RPE65
The rate of degradation of RPE65 was measured in the presence
or absence of MYO7A, using two approaches: mouse eyecups,
with neuroretinas removed, or a stable cell line, expressing
RPE65, LRAT and CRALBP. For the first, retinas were
gently peeled off the RPE, and the remaining eyecups were incu-
bated with 50 mg/ml of CHX (Sigma), in dulbecco’s modified
eagle medium (DMEM) (Gibco) containing 10% fetal bovine
serum (FBS) (Gibco) and 1× MEM (Gibco). Eyecups were col-
lected at 0, 2, 4, 6 and 8 h after the addition of CHX. For the
second approach, 293T-LRC cells that stably expressed
RPE65, LRAT and CRALBP (23) were cultured in DMEM
(Gibco), containing 10% FBS (Gibco) and 1× antibiotics
(Gibco). Cells were plated at a density of 400 000 cells in
six-well plates. The next day, half the wells were transfected
with 1 mg of GFP-MYO7A complexed with Lipofectamine
2000 (Invitrogen), according to the manufacturer’s instructions.
After 48 h, cells were incubated with 50 mg/ml of CHX, and
then collected at 0, 2, 4, 6, 8 and 10 h after the addition of the
CHX. Collected eyecups and cells were lysed in lysis buffer
(50 mM Tris, pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM
MgCl2, 1 mM DTT and complete protease inhibitor cocktail
from Sigma). Equivalent amounts of each sample were run on
an 8% sodium dodecyl sulfate–polyacrylamide gel electrophor-
esis gel and transferred onto PVDF membranes. After immuno-
labeling, the amount of RPE65 was quantified by densitometry.
Retinoid measurements
Shaker1 mice and Myo7a+/+ controls on a 129 Sv background
(homozygous for Leu450 RPE65), at 6 weeks of age, were DA
overnight, and anesthetized with an intraperitoneal injection of
ketamine (4 mg/g body weight) and xylazine (0.8 mg/g body
weight) in saline. Their pupils were then dilated with one drop
of atropine sulfate (1%, w/v, in saline buffer) 30 min before
exposure to 1000 lux in a Ganzfeld dome for 5 min. Mice
were placed in the dark and were euthanized at intervals.
Their eyes were enucleated, the anterior segment was
removed and each resulting posterior eyecup was prepared
and analyzed for retinoid content as described previously (35).
Electroretinography
Full-field ERGs were recorded as previously described
(58,59). Mice were DA (.12 h), anesthetized and their
pupils dilated (59). First, a DA photoresponse was elicited
with a single bright (2.2 log scot-cd s m22) blue flash. After
2 min, a series of three white flashes (3.6 log scot-cd s m22)
were presented in the dark at 5 s intervals, followed by a
2 min exposure to a white background (316 cd/m2) light.
This light exposure (50% photobleach) (60) completely sup-
pressed the ERG a-wave. Recovery of the DA a-wave ampli-
tude was assessed in the dark by presenting the bright blue
stimulus every 10 min for a period of 50 min. Comparisons
were made between congenic shaker1 (sh1/sh1) and heterozy-
gous (+/sh1) mice, with the latter considered as controls (con-
genic WT mice were not available for this experiment). The
mice (1–2 months old) were confirmed to carry the normal
(Leu450) allele of RPE65. Student t-tests were performed
on the data for each time point separately.
Immunoprecipitation
Mouse eyecups were homogenized in 300 mM NaCl, 50 mM
Tris, pH 7, 1% CHAPS, 1 mM DTT and 1× complete protease
inhibitor cocktail (Roche). Homogenates were clarified by
centrifugation for 10 min at 5000g at 48C. For each condition,
1 mg of lysate was diluted to a final volume of 500 ml with the
homogenizing buffer. Samples were incubated with 2 mg of
antibody (anti-RPE65, anti-Myo7a and anti-GST) overnight,
with gentle rotation, at 48C. Fifty microliters of protein
A-sepharose beads (Amersham) were added to each tube and
immune complexes were captured for 2 h at 48C. Captured
complexes were washed three times with lysis buffer, and
boiled for 5 min at 1008C in sodium dodecyl sulfate gel
loading buffer. Ten micrograms of lysate and immune com-
plexes were separated and visualized by western blotting as
described above.
Plasmids
N-terminal-tagged RFP-hRPE65 was generated using standard
cloning strategies. Briefly, human RPE65 cDNA was ampli-
fied from clone 30915627 (Open Biosystems, USA), and
ligated into the XhoI and KpnI restriction sites of
pENTRmRFP (from Dr Ramalho). The construct was con-
firmed by PCR colony screening, digestion of colonies and
by sequencing.
Cotransfection of tagged MYO7A and RPE65
ARPE19 cells, a cell line derived from human RPE cells, were
grown on glass cover slips. They were transfected with
pEGFPC2-hMYO7A and pENTRmRFP-hRPE65, using com-
plexes formed with Lipofectamine2000 (Invitrogen).
Sixteen hours after transfection, cells were washed with
PBS, fixed with 4% (w/v) paraformaldehyde prepared in
PBS for 15 min. After washing, and incubation for 10 min
with 50 mM NH4Cl in PBS, cells were mounted with Fluoro-
Gel (Electron Microscopy Sciences). They were visualized
using a confocal microscope, and images representing single
sections in the z-axis were obtained.
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